| Literature DB >> 26147988 |
Elske Sieswerda1, Anna Font-Gonzalez1, Marcel G W Dijkgraaf2, Ronald B Geskus3, Richard C Heinen1, Helena J van der Pal4, Flora E van Leeuwen5, Huib N Caron1, Leontien C Kremer1, Johannes B Reitsma6.
Abstract
In the Netherlands, the postal code is needed to study hospitalizations of individuals in the nationwide hospitalization register. Studying hospitalizations longitudinally becomes troublesome if individuals change address. We aimed to report on the feasibility and validity of a two-step medical record linkage approach to examine longitudinal trends in hospitalizations and mortality in a study cohort. First, we linked a study cohort of 1564 survivors of childhood cancer with the Municipal Personal Records Database (GBA) which has postal code history and mortality data available. Within GBA, we sampled a reference population matched on year of birth, gender and calendar year. Second, we extracted hospitalizations from the Hospital Discharge Register (LMR) with a date of discharge during unique follow-up (based on date of birth, gender and postal code in GBA). We calculated the agreement of death and being hospitalized in survivors according to the registers and to available cohort data. We retrieved 1477 (94%) survivors from GBA. Median percentages of unique/potential follow-up were 87% (survivors) and 83% (reference persons). Characteristics of survivors and reference persons contributing to unique follow-up were comparable. Agreement of hospitalization during unique follow-up was 94% and agreement of death was 98%. In absence of unique identifiers in the Dutch hospitalization register, it is feasible and valid to study hospitalizations and mortality of individuals longitudinally using a two-step medical record linkage approach. Cohort studies in the Netherlands have the opportunity to study mortality and hospitalization rates over time. These outcomes provide insight into the burden of clinical events and healthcare use in studies on patients at risk of long-term morbidities.Entities:
Mesh:
Year: 2015 PMID: 26147988 PMCID: PMC4493069 DOI: 10.1371/journal.pone.0132444
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flowchart of patients included in the EKZ/AMC cohort of childhood cancer survivors and sampled reference population from the GBA.
Abbreviations: GBA: Dutch acronym for Municipal Personal Records Database; EKZ/AMC: Emma Children’s Hospital/Academic Medical Center
Characteristics of childhood cancer survivors, reference persons and subgroups based on the two-step medical record linkage process.
| Childhood cancer survivors | Reference persons | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Complete survivor (cohort n = 1647) | Survivors eligible for linkage (alive in 1995) (n = 1564) | Survivors linked to GBA (n = 1477) | Survivors contributing to unique follow-up time (n = 1382) | Reference sample from GBA (n = 28255) | Reference persons contributing to unique follow-up time (n = 26583) | ||||||||
| Clinical characteristic | n | % | n | % | n | % | N | % | n | % | n | % | |
| Gender | Male | 905 | 54.9 | 860 | 55.0 | 801 | 54.2 | 738 | 53.4 | 15298 | 54.1 | 14347 | 54.0 |
| Female | 742 | 45.1 | 704 | 45.0 | 676 | 45.8 | 644 | 46.6 | 12957 | 45.9 | 12236 | 46.0 | |
| Year of birth | 1954–1969 | 281 | 17.1 | 235 | 15.0 | 216 | 14.6 | 205 | 14.8 | 4268 | 15.1 | 4066 | 15.3 |
| 1970–1985 | 937 | 56.9 | 900 | 57.5 | 847 | 57.3 | 819 | 59.3 | 15965 | 56.5 | 15462 | 58.2 | |
| 1986–1999 | 429 | 26.0 | 429 | 27.4 | 414 | 28.0 | 358 | 25.9 | 8002 | 28.3 | 7055 | 26.5 | |
| Type of inhabitant | Native inhabitant | na | na | 1227 | 83.1 | 1148 | 83.1 | 20478 | 72.5 | 19461 | 73.2 | ||
| Non-native inhabitant | na | na | 250 | 16.9 | 234 | 16.9 | 7757 | 27.5 | 7122 | 26.8 | |||
| First generation | na | na | 47 | 3.2 | 44 | 2.3 | 4524 | 16.0 | 4137 | 15.6 | |||
| Second generation | na | na | 203 | 13.7 | 190 | 13.7 | 3232 | 11.4 | 2984 | 11.2 | |||
| Year of primary cancer diagnosis | 1966–1974 | 166 | 10.1 | 133 | 8.5 | 122 | 8.3 | 117 | 8.5 | 2411 | 8.5 | 2309 | 8.7 |
| 1975–1984 | 550 | 33.4 | 508 | 32.5 | 479 | 32.4 | 464 | 33.6 | 9199 | 32.6 | 8932 | 33.6 | |
| 1985–1994 | 611 | 37.1 | 603 | 38.6 | 561 | 38.0 | 529 | 38.3 | 10563 | 37.4 | 10037 | 37.8 | |
| 1995–1999 | 320 | 19.4 | 320 | 20.5 | 315 | 21.3 | 272 | 19.7 | 6062 | 21.5 | 5305 | 20.0 | |
| Age at diagnosis | Median (range) | 5.9 | 0–17.8 | 6.8 | 0–17.8 | 5.8 | 0–17.8 | 6.1 | 0–17.8 | 5.9 | 0–18.4 | 6.0 | 0–18.4 |
| 0–4 yr | 723 | 43.9 | 692 | 44.2 | 653 | 44.2 | 607 | 43.9 | 12359 | 46.5 | 11518 | 43.3 | |
| 5–9 yr | 445 | 27.0 | 416 | 26.6 | 395 | 26.7 | 364 | 26.3 | 7620 | 28.7 | 7197 | 27.1 | |
| 10–14 yr | 372 | 22.6 | 351 | 22.4 | 334 | 22.6 | 318 | 23.0 | 6433 | 24.2 | 6118 | 23.0 | |
| 15–18 yr | 107 | 6.5 | 105 | 6.7 | 95 | 6.4 | 93 | 6.7 | 1823 | 6.9 | 1750 | 6.6 | |
| Primary childhood cancer diagnosis | Leukemia/ lymphoma | 740 | 44.9 | 697 | 44.6 | 671 | 45.4 | 624 | 45.2 | na | na | ||
| CNS tumor | 123 | 7.5 | 112 | 7.2 | 102 | 6.9 | 98 | 7.1 | na | na | |||
| Sarcoma | 310 | 18.8 | 292 | 18.7 | 280 | 19.0 | 269 | 19.5 | na | na | |||
| Other solid tumors | 370 | 22.5 | 361 | 23.1 | 388 | 26.3 | 356 | 25.8 | na | na | |||
| Other and unspecified cancers | 42 | 2.6 | 40 | 2.6 | 36 | 2.4 | 35 | 2.5 | na | na | |||
| Specific cancer treatments | Anthracyclines | 687 | 41.7 | 655 | 41.9 | 631 | 42.7 | 586 | 42.4 | na | na | ||
| Alkylating agents | 823 | 50.0 | 783 | 50.1 | 752 | 50.9 | 700 | 50.7 | na | na | |||
| Other chemotherapy | 440 | 26.7 | 417 | 26.7 | 390 | 26.4 | 364 | 26.3 | na | na | |||
| Radiotherapy to head and/or neck region | 454 | 27.6 | 404 | 25.8 | 392 | 26.5 | 374 | 27.1 | na | na | |||
| Radiotherapy to thoracic and/or abdominal region | 356 | 21.6 | 336 | 21.5 | 321 | 21.7 | 302 | 21.9 | na | na | |||
| Radiotherapy to extremities | 118 | 7.2 | 109 | 7.0 | 103 | 7.0 | 92 | 6.7 | na | na | |||
Abbreviations: GBA: Dutch acronym for Municipal Personal Records Database; na: not applicable
a For reference persons: date of cancer diagnosis and age of corresponding childhood cancer survivor.
b All cancer treatment given before the date of five-year survival was included.
Potential follow-up time and unique follow-up time of childhood cancer survivors and reference persons.
| Childhood cancer survivors | Reference persons | |||||
|---|---|---|---|---|---|---|
| Sum | Median | Range | Sum | Median | Range | |
| Potential follow-up time (years) | 14983.9 | 11.0 | 0.1–11.0 | 292234.6 | 11.0 | 0.0–11.0 |
| Unique follow-up time (years) | 10645.6 | 8.8 | 0.1–11.0 | 194208.7 | 8.1 | 0.0–11.0 |
| Unique follow-up time/potential follow-up time (%) | 87 | 1–100 | 83 | 0.1–100 | ||
Agreement between the cohort register and LMR of 195 selected surgical hospitalizations within 156 childhood cancer survivors between 1995 and 2005.
| Subgroup | Hospitalizations | % | Hospitalized persons | % | |
|---|---|---|---|---|---|
| Eligible survivors | 195 | 156 | |||
| Survivors linked to GBA | 192 | 98% | 153 | 98% | |
| Survivors contributing to unique follow-up time | 155 | 81% | 126 | 82% | |
| Retrieved from LMR at same day | 145 | 94% | 121 | 96% | |
| Retrieved from LMR<30 days | 153 | 99% | 125 | 99% | |
Abbreviations: GBA: Dutch acronym for Municipal Personal Records Database; LMR: Dutch acronym for Hospital Discharge Register